I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists.
Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Molecular imaging of infectious and inflammatory diseases: A terra incognita
Published in: Journal of Nuclear Medicine
PET beyond F-18-FDG: second generation PET tracers in clinical oncology
Detection of Intra-Abdominal Testicles with 16 beta-[F-18]-Fluoro-5 alpha- Dihydrotestosterone Positron Emission Tomography/Computed Tomography in a Pubertal Boy
Published in: The Journal of Pediatrics
Nuclear imaging for cardiac amyloidosis
Published in: Heart failure reviews
Histological analysis of endomyocardial tissue is still the gold standard for the diagnosis of cardiac amyloidosis, but has its limitations. Accordingly, there is a need for non-invasive modalities to diagnose cardiac amyloidosis. Echocardiography and ultrasound and magnetic resonance imaging can show characteristics which may not be very specific for cardiac amyloid. Nuclear medicine has gained a precise role in this context: several imaging modalities have become available for the diagnosis and prognostic stratification of cardiac amyloidosis during the last two decades. The different classes of radiopharmaceuticals have the...
PET beyond 18F-FDG: second generation PET tracers in clinical oncology
